Aaberge I S, Løvik M
Department of Vaccinology, National Institute of Public Health, Oslo, Norway.
Scand J Immunol. 1995 Dec;42(6):617-25. doi: 10.1111/j.1365-3083.1995.tb03704.x.
The benefit of re-immunization with pneumococcal polysaccharide vaccine is an important question in clinical practice. In an experimental model, BALB/c and CBA/J mice were re-immunized s.c. with a 23-valent pneumococcal polysaccharide vaccine at various time intervals after a first immunization with the same vaccine. The antibody response after the secondary immunization showed similar kinetics as after primary immunization, and was mainly an IgM antibody response. Re-immunization at 28 days or earlier induced a decrease in the serum antibody levels to the vaccine. Reimmunization at 120 days or later induced higher antibody levels than after the first immunization. Significant increases in antibody levels to serotypes 1, 4, 7F and 19F out of six serotypes tested were observed. In CBA/J mice, but not in BALB/c mice, the dose used for primary immunization appeared to influence the magnitude of the antibody response to secondary immunization. Our results indicate that the time interval between primary and secondary immunization is an important determinant with regard to the magnitude of the antibody response to re-immunization with pneumococcal polysaccharide vaccine.
用肺炎球菌多糖疫苗再次免疫的益处是临床实践中的一个重要问题。在一个实验模型中,BALB/c和CBA/J小鼠在首次用相同疫苗免疫后的不同时间间隔,通过皮下注射用23价肺炎球菌多糖疫苗进行再次免疫。二次免疫后的抗体反应显示出与初次免疫后相似的动力学,且主要是IgM抗体反应。在28天或更早时间再次免疫会导致血清中针对该疫苗的抗体水平下降。在120天或更晚时间再次免疫诱导产生的抗体水平高于初次免疫后。在所测试的六种血清型中,观察到针对1、4、7F和19F血清型的抗体水平有显著升高。在CBA/J小鼠中,但不在BALB/c小鼠中,初次免疫所用剂量似乎会影响对二次免疫的抗体反应强度。我们的结果表明,初次免疫和二次免疫之间的时间间隔是影响肺炎球菌多糖疫苗再次免疫抗体反应强度的一个重要决定因素。